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 Phorbol Ester- and Diacylglycerol-Induced
Augmentation of Transmitter Release
Is Mediated by Munc13s and Not by PKCs
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shape of action potentials, the size and duration of Ca2
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Introduction synaptic strength has become generally accepted. How-
ever, -PEs and many other pharmacological tools used
Changes in the efficacy of synaptic transmission be- to modify PKC function interact equally well with other
tween neurons mediate adaptive properties of the brain -PE receptors (Betz et al., 1998), and several studies
suggest the presence of alternative -PE receptors withand contribute to learning and memory processes. Alter-
a regulatory role in neurotransmitter release (Stevensations of synaptic strength, which are best characterized
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Figure 1. Strategy for the Generation of the Munc13-1H567K Mutation in Mouse Embryonic Stem Cells and Basic Characterization of Homozygous
Mutant Mice
(A) Wild-type Munc13-1 gene (wt), targeting vector, mutated gene after homolgous recombination (mNeo), and mutated gene after Cre recombina-
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(Brose et al., 1995). Munc13-1, the best-characterized but they deteriorate rapidly and die within 2–3 hr after
birth, indicating a general brain stem malfunction. Thefamily member, is specifically localized to presynaptic
active zones (Betz et al., 1998), where it primes synaptic overall structure and cytoarchitecture of brains and the
distribution of the synaptic marker synaptophysin in m/mvesicles to fusion competence by unfolding or “activat-
ing” Syntaxin and thereby promoting core complex for- mutants were indistinguishable from wild-type lit-
termates (data not shown). Heterozygous Munc13-1H567Kmation (Augustin et al., 1999b; Brose et al., 2000; Rich-
mond et al., 2001). Thus, Munc13-1 is a -PE receptor mutants (m/) were identical to wild-type controls in
all analyses (data not shown), demonstrating that thewhose subcellular localization and function establish it
as a potential target of the DAG second messenger Munc13-1H567K protein has no dominant-negative effect.
pathway that may act in parallel with PKCs to enhance
neurotransmitter release (Betz et al., 1998). Genetic Spontaneous and Evoked Synaptic Transmission
studies in C. elegans demonstrated that a specific pre- in Munc13-1H567K/Munc13-1H567K (m/m) Mutants
synaptic regulatory pathway involving cholinergic and To examine the functional consequences of destruction
serotonergic control of motor neurons employs DAG of the DAG/-PE binding site in m/m mutants, we per-
and depends on Unc-13 (Lackner et al., 1999; Miller et formed patch clamp analyses of individual hippocampal
al., 1999; Nurrish et al., 1999). These genetic interactions neurons in microisland cultures. We concentrated on
and data obtained in heterologous expression systems glutamatergic neurons because Munc13-1 function is
(Betz et al., 1998) led to the idea that Munc13 proteins essential for these but not for GABAergic cells (Augustin
and their homologs may be presynaptic targets for DAG et al., 1999b). In these cultures, presynaptic targeting
in vivo. of Munc13-1H567K is indistinguishable from that of wild-
We determined the relative contribution of PKCs and type Munc13-1, as determined by double labeling of
Munc13-1 to the -PE-dependent enhancement of neu- cultured hippocampal neurons with antibodies to
rotransmitter release and to dynamic changes in synap- Munc13-1 and Synaptophysin (Figure 2).
tic efficacy using hippocampal neurons from genetically Routinely, cells from m/m mutants were analyzed
modified mice that express a -PE binding-deficient 12–20 days after plating and compared to wild-type con-
Munc13-1H567K variant instead of the wild-type protein. trol cells obtained from littermates. In some experi-
ments, we employed Munc13-1/Munc13-2 double-defi-
cient neurons as model cells to study the characteristicsResults
of the Munc13-1H567K variant in comparison to wild-type
Munc13-1 following overexpression using the Semliki-Basic Characterization of Mice with a H567K Point
Mutation in the Munc13-1 Gene Forest-Virus system. In contrast to Munc13-1-deficient
glutamatergic hippocampal neurons, which still showMice with a H567K point mutation in the Munc13-1 gene,
which abolishes -PE binding by Munc13-1, were gener- measurable glutamate release (10% of wild-type levels;
Augustin et al., 1999b), double-homozygous Munc13-ated as described in Experimental Procedures (Figure 1).
Like Munc13-1 deletion mutants, homozygous mutant/ 1/Munc13-2-deletion mutant neurons completely lack
spontaneous and evoked transmitter release but can beCre-recombined Munc13-1H567K/Munc13-1H567K mice (m/m)
were not viable. However, they expressed Munc13-1H567K rescued by reintroduction of Munc13 proteins (Rosen-
mund et al., 2002). Autaptic responses were obtainedat levels comparable to those of Munc13-1 in wild-type
littermates (Figure 1E). Thus, intronic insertion of the by brief (1–2 ms) somatic depolarization, which induces
an unclamped action potential that is followed by a post-remaining loxP site does not interfere with mRNA
synthesis, splicing, or stability, and the H567K muta- synaptic response with a delay of 2–4 ms.
Although the perinatally lethal phenotype of m/m micetion does not lead to misfolding or destabilization of
Munc13-1 protein. The ratio of soluble to membrane is similar to that of Munc13-1-deletion mutants, their
electrophysiological characteristics were strikingly dif-bound Munc13-1 was not altered in Munc13-1H567K/
Munc13-1H567K mutants (Figure 1E), indicating that DAG ferent. In contrast to Munc13-1-deficient neurons, m/m
cells produced robust evoked EPSC amplitudes thatbinding by Munc13-1 is not responsible for its tight asso-
ciation with the cytoskeletal matrix. Like Munc13-1 dele- were only slightly smaller than but not statistically differ-
ent from wild-type values (4.87  0.45 nA, n  91, m/m;tion mutants, newborn m/m mice initially breathe, react
to tactile stimuli, and exhibit pain-avoidance reflexes, 5.8  0.7 nA, n  83, wild-type; Figure 3A). Likewise,
tion (m). Exons are indicated by black (C1 domain) or gray (all other) boxes. Black triangles indicate loxP sites. Asterisk indiates H567K
mutation. Black horizontal bar indicates probe used for Southern analysis (Bgl II-digested tail DNA) of mutated genes in mice. Products of
diagnostic PCR reactions (size in brackets) are indicated by horizontal gray bars. Abbreviations are as follows: Neo, neomycin resistance
gene; pBlue, pBluescript KS; and TK, herpes simplex virus thymidine kinase.
(B) Southern blot analysis of mutated genes using Bgl II-digested mouse tail DNA and the probe indicated in (A). Abbreviations are as follows:
mNeo, mutated gene; and wt, wild-type.
(C) PCR analysis of indicated phenotypes using the PCR strategy depicted in (A). Abbreviations are as follows: m, mutated gene after Cre
recombination; mNeo, mutated gene; and wt, wild-type.
(D) Sequence analysis of PCR products obtained with the wt/lox PCR depicted in (A) and (C) using mouse tail DNA as template. Abbreviations
are as follows: wt, wild-type; and m, mutated gene after Cre recombination.
(E) Western blot analysis of brain homogenates from wild-type (wt) and Munc13-1H567K/Munc13-1H567K (m/m) mice. Soluble and particulate
fractions were separated by centrifugation at 300,000  g for 10 min. Proteins were separated by SDS-PAGE and immunoblotted for Munc13-1
using a specific monoclonal antibody to the C terminus of the protein.
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Figure 2. Subcellular Distribution of Munc
13-1H567K
Single-scan confocal image of hippocampal
primary cultures from wild-type (wt) and ho-
mozygous m/m mice (m/m) that were double
labeled for Munc13-1 (Alexa 568-conjugated
secondary antibody, red) and the presynaptic
marker Synaptophysin (Alexa 488-conju-
gated secondary antibody, green). The over-
lay image (right) shows that, irrespective of
the genotype, Munc13-1 labeling coincided
largely with Synaptophysin labeling. This dem-
onstrates that Munc13-1H567K, like wild-type
Munc13-1, is targeted to presynaptic terminals.
mean frequency (3.7  1.3 Hz, n  10, m/m; 4.2  1.9 	M (PDBU), resulting in a slower (16 s time constant)
and smaller increase in evoked EPSC amplitudesHz, n  12, wild-type), amplitude (23.2  1.4 pA, n 
10, m/m; 24.5  1.3 pA, n  12, wild-type), and charge (131%  7% of baseline values, n  34, p  0.001
compared to wild-type control cells; Figure 3D). Control(92  7 pC, n  10, m/m; 96  4 fC, n  12, wild-type)
of spontaneous responses were not different between experiments showed that inactive -PE variants, which
do not bind to C1 domains, had no effect on evokedm/m and wild-type neurons. In a separate set of experi-
ments, we found that evoked EPSC amplitudes from EPSCs in both wild-type (n  9) and m/m neurons (n 
12). Because numerous reports showed -PE-depen-Munc13-2-deficient cells that express Munc13-1 as the
only Munc13 isoform (1.32  0.27 nA, n  17) were dent increases in mEPSC frequency, we examined the
effect of 1 	M PDBU on mEPSC frequency in controlindistinguishable from responses measured in Munc13-1/
Munc13-2 double-deficient neurons overexpressing and m/m neurons. We found that in wild-type neurons,
the mEPSC frequency increased to 239%  34% (n Munc13-1H567K (1.51  0.3 nA, n  21) (Figure 3B). Thus,
inactivation of the DAG/-PE binding site in Munc13-1 8) of control levels, while in m/m cells a much weaker
increase was observed (127%  16% of control levels,leaves the postsynaptic responsiveness of neurons un-
affected and does not abolish priming of synaptic vesi- n  7). These data provide direct evidence that
cles or inhibit their evoked release. Munc13-1 is the main presynaptic target for -PE-medi-
ated enhancement of synaptic transmitter release in hip-
pocampal neurons.Effects of -PEs on Munc13-1H567K/Munc13-1H567K
Although dramatically reduced in comparison to the(m/m) Neurons
wild-type situation, -PE-mediated enhancement ofWe next examined the consequences of the Munc13-1H567K
spontaneous and evoked synaptic transmitter releasemutation for -PE-mediated effects on synaptic trans-
was still detectable in m/m neurons (Figure 3D). To testmission. Wild-type neurons reacted to application of 1
whether this is due to the presence of Munc13-2 (the	M -phorbol dibutyrat (PDBU) for 1 min with a rapid
only Munc13 isoform coexpressed with Munc13-1 in(8 s time constant) and robust enhancement of evoked
glutamatergic hippocampal nerve cells [Augustin et al.,EPSC amplitudes (191%  17% of baseline values, n 
1999a, 2001]), we overexpressed wild-type Munc13-1 or30). Following removal of PDBU, the synaptic amplitude
Munc13-1H567K in Munc13-1/Munc13-2 double-deficientreturned to baseline within 3–4 min (27 s time constant;
neurons using the Semliki-Forest-Virus system andFigure 3C). In contrast, m/m neurons showed a strongly
reduced sensitivity toward -PE with application of 1 tested their sensitivity to -PEs. Similar to wild-type
Munc13s in Presynaptic Signaling
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Figure 3. Effects of the Munc13-1H567K Mutation on Synaptic Responses and Their -PE-Mediated Potentiation
(A) Evoked excitatory autaptic currents from wild-type (n  83) and m/m (n  91) neurons. Error bars indicate standard error of mean.
(B) Synaptic currents from Munc13-2-deficient (n  17) and Munc13-1/Munc13-2 double-deficient cells overexpressing Munc13-1H567K (n 
21). Error bars indicate standard error of mean.
(C and D) Time course of -PE effects on evoked EPSCs in (C) wild-type (n  30) and (D) m/m (n  34) neurons. Application period (1 min)
of -PE dibutyrat (PDBU, 1 	M) or its inactive analog -phorbol (10 	M, assayed in separate experiments) is indicated by a gray box. EPSCs
were evoked at 0.5 Hz and normalized to the initial amplitude. Error bars indicate standard error of mean.
(E) Time course of -PE effects on evoked EPSCs in Munc13-1/Munc13-2 double-deficient cells overexpressing wild-type Munc13-1 (n  12)
or Munc13-1H567K (n  17). Application period (1 min) of -PE dibutyrat (PDBU, 1 	M) is indicated by a gray box. EPSCs were evoked at 0.5
Hz and normalized to the initial amplitude. Error bars indicate standard error of mean.
(F) Average potentiation of evoked EPSC amplitude from experiments shown in (C)–(E) 30 s following onset of PDBU application. Dotted line
is control amplitude. Holding potential 75 mV. Error bars indicate standard error of mean.
neurons, Munc13-1/Munc13-2 double-deficient neu- not PKCs are responsible for the -PE-mediated en-
hancement of neurotransmitter release. This view wasrons overexpressing wild-type Munc13-1 responded to
application of 1 	M PDBU with a rapid and robust in- further supported in a pharmacological analysis of wild-
type hippocampal neurons. We found that the specificcrease in evoked EPSCs (246% 22% of control levels,
n  12; Figures 3E and 3F). In contrast, Munc13- PKC inhibitor GO¨ 6983, a bisindolylmaleimide (BIS) de-
rivative that is thought to specifically interact with ATP1/Munc13-2 double-deficient cells overexpressing
Munc13-1H567K were completely insensitive to 1 	M binding sites of several PKCs, had no effect on the -PE-
induced increase in evoked EPSCs (160% 9% of base-PDBU (108%  5% of control levels, n  17; Figures
3E and 3F), although evoked EPSC amplitudes were line values, n  10, with 1 	M PDBU alone; 150%  6%
of baseline values, n  10, after preincubation for 2 minreconstituted to control levels (Figure 3B). Thus, -PE-
dependent enhancement of presynaptic transmitter re- and in the presence of 3 	M GO¨ 6983). This shows that
GO¨ 6983-sensitive PKCs are not involved in the -PElease from hippocampal neurons is entirely dependent
on the presence of Munc13-1 and Munc13-2. effects observed here. In addition, we examined the
effects of BIS I (GO¨ 6850), a widely used but somewhatThe above results are in conflict with the widely held
view that PKCs are the main -PE targets in the presyn- less specific inhibitor of PKCs. We first treated wild-
type neurons for 1 min with 1 	M PDBU and measuredapse. Published conclusions about the role of PKCs in
the regulation of transmitter release are largely based the induced increase of evoked EPSC amplitudes at 0.2
and 0.033 Hz stimulation frequencies (50%–60% in-on indirect pharmacological evidence. Data from our
genetic approach, however, suggest that Munc13s and crease over baseline, n  7 each; Figures 4A and 4C).
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through an unknown, possibly toxic mechanism (e.g.,
by influencing RRP refilling rates), but does not prevent
the -PE-induced potentiation of transmitter release.
Expression and Function of PKCs in Munc13-1H567K/
Munc13-1H567K (m/m) Neurons
In principle, the data presented so far would also be
compatible with the view that the H567K point mutation
in Munc13-1 influences levels or function of PKCs. To
test this directly, we first examined the protein expres-
sion levels of PKCs by densitometric analysis of Western
blots obtained with brain homogenates from wild-type
and m/m mice. We found that protein levels of all tested
PKCs were unaffected by the m/m mutation (Figures 5A
and 5B). Second, we analyzed -PE-dependent PKC
activity in cultures from wild-type and m/m mutant
brains. Cortical/hippocampal primary cultures were
loaded with [32P]orthophosphate and stimulated with 1
	M PDBU. Labeled proteins were separated by 2D elec-
trophoresis and visualized autoradiographically. Autora-
diographs of wild-type and m/m cultures showed identi-
cal patterns of proteins that were phosphorylated in a
-PE-dependent manner (Figure 5C), demonstrating
that overall -PE-dependent PKC activity is not affected
by the m/m mutation. Third, we examined the -PE-
dependent phosphorylation of two identified presynap-
tic targets of PKCs, SNAP-25 (Shimazaki et al., 1996)
and GAP-43/B-50 (de Graan et al., 1994). We prepared
cultures from wild-type and m/m brains, which were then
stimulated with 1	M PDBU, harvested, and analyzed by
SDS-PAGE and Western blotting using phosphopep-
tide-specific antibodies (Iwasaki et al., 2000; Kawakami
et al., 2000). Again, we detected no differences betweenFigure 4. Pharmacology of -PE-Induced Potentiation in Wild-Type
the tested genotypes with respect to PKC activity.Neurons
SNAP-25 and GAP-43 were strongly phosphorylated in(A) Time course of -PE effects on evoked EPSCs (0.2 Hz) in wild-
a -PE-dependent manner in both wild-type and m/mtype neurons (n  7). Application of PDBU (1 	M) is indicated by a
black bar. Application of BIS 1 (3 	M) is indicated by a gray box. cultures (Figure 5D). Thus, PKC-dependent phosphory-
Incubation of bisindoylmaleimide I led to a partially irreversible run- lation of synaptic targets is normal in m/m mutants.
down of evoked EPSC amplitudes but did not block the potentiation Finally, we tested whether Munc13-1 acts as a substrate
induced by application of PDBU (1 	M) for 1 min (white box). for PKCs and whether PKC-dependent phosphorylation
(B) Average evoked EPSC amplitudes after treatment with bisindoyl-
of Munc13-1 is affected by the H567K mutation. Wemaleimide I (normalized to control values before drug application).
used cortical/hippocampal primary cultures from wild-Note that the degree of rundown induced by bisindoylmaleimide
I is dependent on the stimulation frequency and larger at higher type and m/m brains, which were loaded with [32P]ortho-
frequencies (n  7 for each frequency). phosphate and stimulated with 1 	M PDBU. Proteins
(C) Average -PE-mediated potentiation in untreated (Bis) and were extracted with detergent, and Munc13-1 was im-
bisindoylmaleimide I (3 	M) pretreated (Bis) neurons, calculated munoprecipitated using a specific polyclonal antibody
by dividing the evoked EPSC amplitude 30 s following the applica-
(Betz et al., 1997). Phosphorylated and immunoprecipi-tion by that immediately before application of 1 	M PDBU (n  7
tated material was separated by SDS-PAGE and ana-for each frequency/treatment group).
lyzed by autoradiography. In parallel, aliquots of the
same samples were analyzed by Western blotting for
Munc13-1 and densitometric analysis. We found thatFollowing washout of PDBU, application of BIS I (3 	M)
Munc13-1 was weakly phosphorylated in a constitutive,led to a partial and irreversible rundown of evoked EPSC
-PE-independent manner in all genotypes tested (Fig-amplitudes. The degree of this rundown was dependent
ure 5E). However, in wild-type and m/m brains, a -PE-on the stimulation frequency (35% at 0.2 Hz, n  7, and
dependent phosphorylation of Munc13-1 was not ob-15% at 0.033 Hz, n  7, over a 4 min application period;
served. The ratio between immunoprecipitated andFigures 4A and 4B). However, the resulting reduced
phosphorylated Munc13-1 was very similar between allevoked EPSC responses were still potentiated by appli-
genotypes and treatment groups, indicating thatcation of 1	M PDBU, and the degree of this potentiation
Munc13-1 is not a PKC target (Figure 5E).was similar to the one observed with PDBU alone (Fig-
ures 4A and 4C). A very similar BIS I-dependent reduc-
tion of evoked EPSC amplitudes was seen in m/m neu- Functional Consequences of the Munc13-1H567K
Mutation for Synaptic Transmissionrons (data not shown), indicating that this rundown is
not directly related to the function of the Munc13-1 C1 We next investigated the physiological role of DAG-
dependent regulation of transmitter release and the roledomain. Thus, BIS I acts on evoked EPSC responses
Munc13s in Presynaptic Signaling
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Figure 5. Expression and Function of PKCs in Munc13-1H567K/Munc13-1H567K (m/m) Neurons
(A) Western blot analyses of various PKCs and Synaptophysin (Syp) in brain homogenates from a wild-type (wt) and a m/m (m/m) brain.
(B) Quantitative analysis of PKC levels determined by Western blotting. Protein levels in m/m brains are expressed as % of wild-type controls.
Respective n values are given at the base of histogram bars. Note that PKC and PKC are orthologs and PKC is not shown in (A). Syp
indicates synaptophysin. Error bars indicate standard error of mean.
(C) Autoradiographs of 2D gels (selected sections) obtained from 32P-labeled cultures of wild-type (wt) and m/m (m/m) brains in the absence
or presence of -PE (1 	M PDBU). Arrows indicate proteins that are specifically phosphorylated in a -PE-dependent manner.
(D) -PE-dependent phosphorylation of SNAP-25 and GAP-43 in wild-type (wt) and m/m (m/m) cultures. Cultures were treated as decribed
in Experimental Procedures. Identical amounts of proteins were separated by SDS-PAGE and probed with specific antibodies for phosphorylated
SNAP-25 (SNAP-25-Pi), total SNAP-25 (SNAP-25), and phosphorylated GAP-43 (GAP-43-Pi).
(E) Test for -PE-dependent phosphorylation of Munc13-1. Wild-type (wt) and m/m (m/m) cultures were labeled with [32P]orthophosphate and
stimulated with 1 	M PDBU. Proteins were extracted and Munc13-1 was immunoprecipitated using specific polyclonal antibodies (Munc13-1 IP)
or control preimmune serum (Control IP). Immunoprecipitated material as well as the extract before precipitation (Load) were separated by
SDS-PAGE. Labeled proteins were visualized by autoradiography. Immunoprecipitated Munc13-1 was detected by immunoblotting with a
specific monoclonal antibody. Asterisks indicate Munc13-1 bands.
of Munc13-1 in this process by examining RRP sizes 6C), indicating that increased Pvr is a consequence of
the Munc13-1H567K mutation. To investigate how this Pvrand release dynamics in m/m and wild-type control cells.
We determined RRP size by quantifying the transient increase in m/m cells affects the synaptic release proba-
bility Pr, we estimated Pr by analyzing the use-depen-burst of exocytotic activity following application of hy-
pertonic sucrose solution (Stevens and Tsujimoto, 1995; dent, progressive block of NMDA-EPSCs in the pres-
ence of MK-801, which reflects the release probabilityRosenmund and Stevens, 1996). The RRP was signifi-
cantly smaller in m/m neurons (0.58 0.11 nC or 6373 across all synapses of a given neuron (Rosenmund et
al., 1993, Hessler et al., 1993). This method samples660 vesicles, n  81) than in wild-type control cells
(1.04  0.11 nC or 10947  1157 vesicles, n  72, most glutamatergic synapses, including silent synapses
that are not contributing to AMPA-mediated EPSCs.p  0.001) (Figure 6A). However, using a paired pulse
stimulation paradigm with consecutive hypertonic su- Control and m/m cells showed a similar initial fast decay
of EPSC amplitudes as a function of stimulus number,crose pulses at variable interpulse intervals, we found
that the rate by which the RRP was refilled after com- while the slower component of the EPSC decay ap-
peared to be somewhat, but not significantly, smaller inplete depletion was unaffected by the m/m mutation
(Figure 6B). m/m cells (Figure 6D).
The shift in release probabilities observed in m/m mutantUnaltered evoked EPSC amplitudes (Figure 3A) to-
gether with reduced RRP size (Figure 6A) indicate an neurons is predicted to have consequences for synaptic
short-term plasticity and transmission during high-fre-increase in the average vesicular release probability Pvr
in m/m cells. Calculated Pvr, obtained by dividing the quency stimulation. We therefore monitored the stability
of evoked EPSCs at action potential frequencies of 1–10quantal content of the average evoked EPSC by the
RRP size, was 10.5%  0.8% (n  81) for m/m and Hz. Compared to wild-type responses, evoked EPSC am-
plitudes of m/m neurons showed more pronounced de-6.9%  0.6% (n  72) for wild-type cells (p  0.001,
Figure 6C). Similar increases in Pvr over wild-type control pression (steady-state versus initial amplitude of the train)
at all frequencies tested (Figures 7A–7C). This aberrantcells were observed in Munc13-1/Munc13-2 double-
deficient neurons overexpressing Munc13-1H567K (Figure synaptic depression during high-frequency stimulation,
Cell
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Figure 6. Readily Releasable Vesicle Pool
and Release Probability in Wild-Type and
Munc13-1H567K/Munc13-1H567K (m/m) Neurons
(A) Example traces of responses (top) and
average transient charge component (bot-
tom) of release of the readily releasable vesi-
cle pool in glutamatergic neurons induced by
hypertonic sucrose solution (500 mOsm hy-
pertonic, 4 s). Asterisk indicates significant
reduction (p 0.001) of the readily releasable
vesicle pool in m/m (n  81) over wild-type
control neurons (n  72).
(B) Refilling kinetics of the readily releasable
vesicle pool under resting conditions as mea-
sured in a paired pulse protocol consisting
of two 4 s applications of hypertonic solution
at varying interpulse intervals. The transient
charge component of the second response
was divided by the first response.
(C) Average vesicular release probability Pvr
of wild-type (n  72) and m/m neurons (n 
81) as well as Munc13-1/Munc13-2 double-
deficient neurons overexpressing Munc13-
1H567K (rescue; n 17) was calculated by divid-
ing the evoked EPSC charge by the charge
of the response following depletion of the
readily releasable vesicle pool with hyper-
tonic solution. Asterisks indicate significant
increase (p  0.01) of Pvr over wild-type con-
trol neurons.
(D) Synaptic release probability as deter-
mined by NMDA-EPSC amplitude decay dur-
ing ongoing EPSC stimulation in the presence
of the irreversible NMDA open channel
blocker MK-801 (5 	M). EPSC amplitude was
normalized to the first response in the pres-
ence of MK-801. External solution contained
2.7 mM Ca2, no Mg2, and 10 	M glycine.
Stimulation frequency was 0.33 Hz.
which was already detectable with the second stimulus, end of the 40 Hz train (Figure 8A). We found that m/m
neurons recovered more slowly from RRP depletion thanwas even more pronounced when we tested characteris-
tics of Munc13-1H567K after Semliki-Forest-Virus-mediated wild-type cells (  1.52 s, n  8, in m/m cells versus
  0.81 s, n 12, in wild-type cells; Figure 8A). Second,overexpression on the Munc13-1/Munc13-2 double-dele-
tion background. Synaptic depression at 10 Hz stimulation we continuously stimulated neurons at 10 Hz and inter-
mittently depleted the RRP with a hypertonic sucrosefrequency in Munc13-1/Munc13-2 double-mutant cells
overexpressing wild-type Munc13-1 was comparable to pulse (4 s; Figure 8B). Following return to normal osmo-
larity, the EPSC amplitude returned to a steady-statethat seen in wild-type cells (Figures 7B and 7D). In contrast,
Munc13-1/Munc13-2 double-mutant neurons overex- amplitude within seconds. We first analyzed the time
course of this recovery. Both m/m neurons (  0.88 pressing Munc13-1H567K showed a degree of synaptic de-
pression that even exceeded that of m/m mutant neu- 0.09 s, n  36, p  0.015) and Munc13-1/Munc13-2
double-deficient neurons overexpressing Munc13-1H567Krons (Figure 7D), most likely because the contribution
of wild-type Munc13-2 is lacking in these cells. (  0.93  0.10 s, n  14, p  0.015) showed a signifi-
cantly slower recovery time constant than wild-typeOur data on m/m neurons obtained with high-frequency
stimulation paradigms demonstrate that an intact C1 do- neurons (  0.61  0.047 s, n  29; Figure 8C). As a
more direct measure of the activity-dependent refillingmain in Munc13-1 is essential for the maintenance of high
levels of transmitter release during high-frequency action kinetics, we determined the initial slope of recovery fol-
lowing return to normal osmolarity, which representspotential trains. However, we already showed that the
refilling rate of the RRP as determined by responses to the rate by which new vesicles arrive. To allow direct
comparison of RRP refilling between cells, we ex-paired hypertonic sucrose pulses (i.e., in the absence
of activity) is normal in m/m neurons (Figure 6B). We pressed this rate in pool units/second by normalizing
EPSC responses during recovery to the initial EPSCexamined a possible role for the Munc13-1 C1 domain
in activity-dependent refilling of the RRP using two ex- amplitude at the beginning of the train (defined as 1
pool unit). Both m/m neurons (0.13  0.01 pool units/perimental paradigms. First, we depleted the RRP by a
40 Hz/2.5 s stimulation train and determined the recov- s, n  36, p  0.001) and Munc13-1/Munc13-2 double-
deficient neurons overexpressing Munc13-1H567K (0.059 ery rate of the evoked EPSC amplitude (i.e., the refilling
rate of the RRP) by measuring the EPSC response to a 0.01 pool unit/s, n  14, p  0.001) had strongly reduced
refilling kinetics compared to wild-type cells (0.29 0.027single stimulus given at different time intervals after the
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Figure 7. Release Dynamics in Wild-Type and Munc13-1H567K/Munc13-1H567K (m/m) Neurons
(A and B) Normalized evoked EPSC amplitudes of wild-type (n  8) and m/m neurons (n  16) at (A) 1 Hz and (B) 10 Hz stimulation rates.
(C) Depression of EPSC amplitudes during action potential trains of 1, 2.5, 5, and 10 Hz as calculated from steady-state amplitude divided
by first amplitude of the train (n  6–8 for wild-type and n  15–16 for m/m neurons).
(D) Comparison of 10 Hz depression time course between m/m neurons (black circles; n  19) and Munc13-1/Munc13-2 double-deficient
neurons overexpressing wild-type Munc13-1 (gray squares; n  13) or Munc13-1H567K (open circles; n  19). Note that depression is less
pronounced in the m/m neurons, presumably because of a remaining fraction of synapses that employ Munc13-2.
pool unit/s, n  29; Figure 8D). Thus, Munc13-1 partici- the disruption of a hypothetical signaling cascade that
pates in the activity-dependent refilling of the RRP, with is initiated by PKCs and propagated by Munc13s.
its C1 domain acting as an activity sensor. This conclusion is in conflict with most published
views of PKC function in the control of neurotransmitter
release. However, many previously published data indi-Discussion
cating a role for PKCs in the regulation of transmitter
release are equally compatible with alternative interpre--PE-Mediated Enhancement of Transmitter
tations. Most published PKC studies depended on phar-Release: Munc13s versus PKCs
macological tools whose specificity is still poorly char-The most striking conclusion of the present study is that
acterized. We found here that BIS I/GO¨ 6850, one ofin hippocampal neurons, Munc13s and not PKCs are
the most frequently used “PKC-specific” drugs, inhibitsthe only receptors involved in the acute regulation of
neurotransmission even in the absence of -PEs (Figurepresynaptic transmitter release by -PEs or DAG. This
4). This effect compromises the use of this drug as aview is based on three key findings First, mutant m/m
pharmacological tool. Moreover, an alternative PKC in-neurons exhibit a dramatic reduction in -PE sensitivity
hibitor, GO¨ 6983, had no effect on the -PE-inducedof transmitter release (Figures 3C and 3D). This reduc-
increase in transmitter secretion studied here. Thus,tion is complete when the contribution of wild-type
published pharmacological data on the role of PKCs inMunc13-2 is abolished (Figures 3E and 3F). Second,
the regulation of transmitter release have to be interpre-expression and -PE-dependent activity of PKCs are
ted with care. Indeed, the only case where an alternativenormal in m/m neurons (Figure 5). Therefore, the conse-
approach was taken (genetic deletion of PKC in mice;quences of the Munc13-1H567K mutation are not due to
Goda et al., 1996) gave no evidence for an involvementan indirect effect on PKCs. Third, Munc13-1 is not a
of PKCs in the regulation of transmitter release, andPKC substrate (Figure 5) and therefore unlikely to act
several studies indicate the presence of alternative func-as a downstream effector of PKCs. Thus, the conse-
quences of the Munc13-1H567K mutation are not due to tional -PE receptors in the presynapse because -PE
Cell
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Figure 8. Activity-Dependent Refilling of Readily Releasable Vesicle Pools in Munc13-1H567K/Munc13-1H567K (m/m) Neurons
(A) Recovery of evoked EPSC amplitudes following depletion of the pool by a 2.5 s/40 Hz stimulation train. A 2.5 s train of 40 Hz stimulation
was applied to excitatory cells in order to deplete the readily releasable vesicle pool (left). Single stimuli were then given at different intervals
after the train in order to determine the time course of recovery of the evoked EPSC response to pretrain baseline values (right; all amplitude
values are normalized to the pretrain baseline). Note that EPSC amplitudes in m/m neurons recover more slowly from pool depletion ( 
1.52 s) than under wild-type conditions (  0.81).
(B) Recovery of evoked EPSC amplitudes following depletion of the pool by hypertonic sucrose application during ongoing 10 Hz stimulation.
A train of 10 Hz was applied to excitatory cells. After 5 s of stimulation at 10 Hz (data not shown), the readily releasable vesicle pool was
intermittendly depleted by an application of hypertonic solution for 4 s (gray bar), and the recovery of the synaptic response during ongoing
10 Hz stimulation was monitored for another 10–20 s. Shown are average evoked EPSC amplitudes of wild-type (black circles; n  29) and
m/m cells (gray circles; n  36), as well as of Munc13-1/Munc13-2 double-deficient neurons overexpressing Munc13-1H567K (open circles; n 
14) as they recover from depletion upon return to normal osmolarity. The amplitudes were normalized to the initial EPSC amplitude in the
train. It was assumed that the initial amplitude results from a fully filled readily releasable vesicle pool (1 pool unit).
(C) Time constants of recovery of evoked EPSC amplitudes following removal of hypertonic solution, calculated by an exponential fit of data
set in (B). Values of n as in (B). Asterisks indicate significant change compared to wild-type cells (p  0.015). Note that the recovery time
constant is also influenced by the rate of depletion.
(D) Initial slope of recovery of evoked EPSC amplitudes following return to normal osmolarity, calculated from data set shown in (B). Values
of n as in (B). Asterisks indicate significant change compared to wild-type cells (p  0.015).
effects were not completely reversed by PKC inhibitors were shown to be distinct with respect to time course,
dependence on -PE concentration, and sensitivity to(Stevens and Sullivan, 1998; Honda et al., 2000; Hori et
al., 1999; Redman et al., 1997; Iwasaki et al., 2000; Wa- PKC inhibitors and less-specific kinase blockers.
Our data only allow conclusions about the relativeters and Smith, 2000). In the most striking example (Iwa-
saki et al., 2000), -PE-mediated effects on protein importance of Munc13s and PKCs in the control of neu-
rotransmitter release from hippocampal neurons. How-phosphorylation by PKCs and secretion in PC12 cells
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ever, in view of the present study and the fact that two-pool model would explain why m/m neurons show
increased Pvr, i.e., normal EPSC amplitudes, despite re-ubMunc13-2 is also expressed in nonneuronal tissues
(Song et al., 1998; Betz et al., 2001), a reevaluation of duced RRPs. The observed increases in paired pulse
depression and synaptic depression rate at 1–10 Hzreported PKC-mediated effects in nonneuronal tissues
is required. Evidence for functional non-PKC -PE re- stimulation frequencies and lower steady-state ampli-
tudes during trains of stimuli (Figure 7) are predictedceptors in more general processes such as protein ex-
port from the ER has already been provided (Fabbri et consequences of the increased apparent Pvr seen in
m/m neurons. The reduced activity-dependent refillingal., 1994).
rates in m/m neurons (Figure 8) can be explained by a
lack of “activation” of the low Pvr pool for secretion byRegulation of Munc13-1 Function
high-frequency stimulation or -PEs.via the C1 Domain
A molecular model of how Munc13-1 activity may de-Analyses of release and pool dynamics in m/m neurons
fine two different pools of releasable vesicles can berevealed a surprising insight into the function of the
inferred from the mechanism of DAG-dependent mem-Munc13-1 C1 domain. We found that the RRP size was
brane recruitment of PKCs. Munc13-1 is present in areduced in m/m neurons under resting conditions (Fig-
soluble pool and in a pool that is tightly associated withure 6A), but activity-independent refilling of the RRP
the cytoskeletal matrix of the presynaptic active zonewas normal (Figure 6B). Thus, the m/m mutation does
by a proteinaceous linker (Figure 1E; Betz et al., 2001),not simply cause a retardation of RRP refilling rates in
and soluble Munc13-1 can translocate to the plasmathe resting state. In addition, we observed that evoked
membrane in a -PE-dependent manner (Betz et al.,EPSC amplitudes were hardly affected in m/m neurons
1998; Ashery et al., 2000). The insoluble, active zone(Figure 3A) despite an underlying reduction in the size
resident Munc13-1 pool may define the pool of slowlyof the RRP (Figure 6A), indicating that the remaining
refilling, high Pvr vesicles because it is functionally inte-vesicle pool has an intrinsically higher vesicular release
grated into the release machinery of the active zone andprobability (Pvr) than the average release probability in
has access to all necessary regulatory proteins (Betz etneurons with an intact Munc13-1 C1 domain. This effect
al., 2001). In contrast, the pool that is dependent on theof the m/m mutation on Pvr has striking consequences for
Munc13-1 C1 domain and characterized by fast refillingthe activity-dependent regulation of transmitter release,
rates but low Pvr may be generated by Munc13-1 mole-since it leads to aberrant synaptic depression during
cules that have been recruited from the cytosol to thetrains of action potentials (Figure 7) and retarded refilling
presynaptic plasma membrane in a DAG-dependent man-of RRPs during/after high-frequency stimulation (Figure
ner. These recruited, nonactive zone resident Munc13-18). These findings indicate that Munc13-1, in addition
molecules could represent “ectopic” priming sites thatto mediating basal synaptic vesicle priming (Augustin
are partially functional but lack active zone-specific reg-et al., 1999b), participates in the maintenance of RRPs
ulatory components, hence their fast refilling rate andduring high-action potential frequencies. High-fre-
low Pvr. In the absence of stimulation, the number ofquency stimulation appears to cause Ca2 influx, activa-
ectopic priming sites would be dependent on the restingtion of phospholipase C, and transient increases in syn-
DAG level in the presynaptic active zone plasma mem-aptic levels of DAG, which in turn binds to the C1 domain
brane. Tonically present ectopic priming sites would beof Munc13-1 and boosts its priming activity. The fact
largely eliminated in m/m neurons, leading to a reductionthat m/m mice die immediately after birth indicates that
in the size of the readily releasable vesicle pool (Figurethe C1 domain-dependent stimulation of Munc13-1 ac-
6A). The number of ectopic sites would be increased bytivity and the concomitant adaptation to high-activity
activity-dependent increases in membrane DAG levelslevels may be important for neurons involved in essential
or by -PEs, which indeed cause increases in the size ofbody functions (e.g., rhythmically active nerve cells in
the readily releasable vesicle pool (Stevens and Sullivan,the respiratory system).
1998).It is unclear how Munc13-1 via its C1 domain regulates
Currently, the endogenous transmitter systems andPvr and the refilling of the RRP in an activity-dependent
signal transduction pathways that target Munc13s in themanner. Munc13-1 binding to its putative substrate Syn-
mammalian brain are unknown. The main task of futuretaxin is not affected by -PEs (A.B. and N.B., unpub-
studies will be to identify and characterize endogenouslished data). One possibility is that wild-type hippocam-
transmitter and second messenger systems that controlpal neurons, like other cells (Voets, 2001; Sakaba and
Munc13 function by regulating DAG levels.Neher, 2001a, 2001b), form two functionally distinct
pools of releasable vesicles. One pool is reluctantly re-
Experimental Proceduresleasable (low Pvr) but quickly replenished and contrib-
utes only weakly to action potential-induced release at
Stem Cell Experiments
low-stimulation frequencies. Processes such as ongoing A previously published mouse genomic clone (pM13-27.1; Augustin
synaptic activity or direct activation of the Munc13-1 C1 et al., 1999b) was used to construct a targeting vector for the genera-
tion of Munc13-1H567K mutant mice by homologous recombination indomain increase the size of or facilitate release from
embryonic stem cells (Figure 1A). In the targeting vector, a Neomycinthis low Pvr pool. The m/m mutation abolishes it, resulting
resistance gene flanked by two loxP sites was inserted in antisensein an apparent increase in average Pvr. The other pool
orientation into an intronic sequence between a short arm with theis readily releasable (high Pvr) but slowly replenished, is exon encoding the Munc13-1 C1 domain and a long arm with aboutthe main contributor to evoked release at low-stimula- 8 kb of genomic sequence containing multiple exons. In addition,
tion frequencies, is unaffected in m/m cells, and thus, two copies of the HSV thymidine kinase gene were attached 5 to
the short arm for negative selection. The short arm was generatedis independent of Munc13-1 C1 domain function. This
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by PCR using the mouse genomic sequence as template and de- the Mini Protean II System (Bio-Rad) for the second dimension. Gels
were dried and analyzed by autoradiography. Immunoprecipitationsigned to contain three point mutations, one silent to generate a
Hind III site for diagnostic purposes, and two to generate the H567K of Munc13-1 was done as described with a specific polyclonal anti-
body (N395; Betz et al., 1997). Separated proteins were blotted tomutation (Figure 1D). Mice carrying the mutated Munc13-1H567K/Neo
gene (mneo) were generated as described (Augustin et al., 1999b) nitrocellulose and analyzed by immunoblotting with a monoclonal
antibody to Munc13-1 (Betz et al., 1998) and ECL (Amersham Phar-and identified by Southern blotting (Figures 1A and 1B). Once homol-
ogous recombination and germline transmission of the mutation macia Biotech). Immunoprecipitated Munc13-1 was quantified den-
sitometrically. Phosphorylation of SNAP-25 and GAP-43 was ana-had been verified, mice were routinely genotyped by PCR (Figures
1A and 1C). Like Munc13-1-deletion mutants (Augustin et al., 1999b), lyzed by stimulating cortical/hippocampal neurons with 1 	M PDBU
for 30 min. Cells were then washed with PBS and harvested for directanimals homozygous for the mutated Munc13-1H567K/Neo gene (mneo/
mneo) were not viable and contained no Munc13-1H567K protein (data analysis by SDS-PAGE and immunoblotting using phosphopeptide-
specific antibodies (Iwasaki et al., 2000; Kawakami et al., 2000).not shown), most likely because the integration of the Neomycin
resistance gene in antisense orientation into the intronic sequence
flanking the C1 domain exon compromises Munc13-1 mRNA synthe- Acknowledgments
sis or splicing. To eliminate deleterious effects of the Neomycin
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